Isturisa (osilodrostat) is now approved in the U.S. for adults with Cushing’s disease for whom pituitary…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Symptoms associated with the risk of heart disease or stroke are common in people with asymptomatic tumors of…
While men and women with adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome have distinct symptoms and signs, these differences do…
Data from an ongoing real-world study show that treatment with Signifor (pasireotide) is able to normalize cortisol…
Measures of the degree of fat in bone marrow could be a reliable marker of bone health, helping doctors to…
A pooled analysis of studies and data from a single center in Brazil suggest that people with Cushing’s disease…
Mifepristone, a synthetic steroid commonly used to taper high blood sugar levels and diminish insulin resistance in patients with…
Mifepristone, a medicine that blocks glucocorticoid hormone effects, may be useful for preventing adrenal insufficiency in people…
Ultrasound scans can be useful to monitor muscle changes in patients with glucocorticoid-induced muscle disease or steroid myopathy, and could…
Competent physicians and long-term medical care are the types of support that most help patients with Cushing’s syndrome…